Evestra’s focus is the development of innovative products which have a high probability of success. Current research falls in two categories:

New steroid molecules for unmet medical needs

New drug delivery technology, especially vaginal rings

Evestra has established a network of US and international organizations with experience in hot melt extrusion from academic laboratories to commercial manufacturing. Technology development is based on the extensive experience of our teams of staff members and scientific advisors. The established, and expanding IP portfolio enables the targeted delivery of drugs in a variety of women's healthcare areas such as fertility control, hormone replacement therapy and gynecological indications.

Evestra is developing its products through proof of concept (POC) followed by commercialization through corporate partnerships.